Zinc as an adjunct treatment for reducing case fatality due to clinical severe infection in young infants: study protocol for a randomized controlled trial

Zinc as an adjunct treatment for reducing case fatality due to clinical severe infection in young infants: study protocol for a randomized controlled trial

Abstract Background An estimated 2.7 of the 5.9 million deaths in children under 5 years of age occur in the neonatal period. Severe infections contribute to almost a quarter of these deaths. Mortality due to severe infections in developing country settings is substantial despite antibiotic therapy....

Full description

Bibliographic Details
Main Authors: Nitya Wadhwa, Sudha Basnet, Uma Chandra Mouli Natchu, Laxman P. Shrestha, Shinjini Bhatnagar, Halvor Sommerfelt, Tor A. Strand, the zinc sepsis study group, Siddarth Ramji, K. C. Aggarwal, Harish Chellani, Anuradha Govil, Mamta Jajoo, N. B. Mathur, Meenakshi Bhatt, Anup Mohta, Imran Ansari, Srijana Basnet, Ram H. Chapagain, Ganesh P. Shah, Binod M. Shrestha
Format: Article
Language:English
Published: BMC 2017-07-01
Series:BMC Pharmacology and Toxicology
Subjects:
Sepsis
Severe infection
Infants
Neonate
Zinc
India
Online Access:http://link.springer.com/article/10.1186/s40360-017-0162-5

Internet

http://link.springer.com/article/10.1186/s40360-017-0162-5

Similar Items